Study on Preliminary Safety and Efficacy of the ARC-IM Therapy to Support Hemodynamic Management in People With Typical and Atypical Parkinson's Disease
The PD-HemON study aims to evaluate the safety and preliminary efficacy of ARC-IM Therapy (Epidural Electrical Stimulation) to support hemodynamic management in people with typical and atypical Parkinson's Disease, who suffer from orthostatic hypotension.
• \> 18 years old
• Typical or Atypical PD (including but not limited to Multiple System Atrophy, Pure Autonomic Failure, Progressive Supranuclear Palsy)
• Confirmed orthostatic hypotension with a test for verticalization
• Confirmed symptomatic orthostatic hypotension that makes daily activities particularly challenging as determined by the study clinicians
• Must provide and sign the Informed Consent before any study-related procedures
• Stable medical, physical, and psychological conditions given participant indication as considered by Investigators;
• Able to understand and interact with the study team in French or English
• Agrees to comply in good faith with all conditions of the study and to attend all scheduled appointments